Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 328

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 19
Chunk 328
---
 23, 2021.  

  (2)      Incorporated by reference to Exhibit 1 of the Registration Statement on Form F-6EF (No. 333-218969) filed by the Bank of New York Mellon on June 26, 2017 with respect to the Registrant’s Americ...  

  (3)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F filed on March 23, 2017.  

  (4)      Incorporated by reference to the Registrant’s Registration Statement on Form 20-F (No. 001-35223) filed on July 1, 2011.  

  (5)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F filed on March 10, 2016.  

  (6)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F/A filed on May 31, 2016.  

  (7)      Incorporated by reference to the Registrant’s Form 6-K filed on October 3, 2018.  

  (8)      Incorporated by reference to the Registrant’s Form 6-K filed on May 27, 2022.  

  (9)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F filed on March 12, 2020.  

  (10)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F filed on March 23, 2015.  

  (11)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F/A filed on September 22, 2015.  

  (12)      Incorporated by reference to the Registrant’s Form 6-K filed on February 7, 2019.  

  (13)      Incorporated by reference to the Registrant’s Form 6-K filed on January 21, 2021.  

  (14)      Incorporated by reference to the Registrant’s Form 6-K filed on September 3, 2021.  

  (15)      Incorporated by reference to the Registrant’s Form 6-K filed on September 15, 2022.  

  (16)      Incorporated by reference to the Registrant’s Form 6-K filed on September 21, 2022.  

  (17)      Incorporated by reference to the Registrant’s Annual Report on Form 20-F filed on March